NYSE - Delayed Quote • USD
Haemonetics Corporation (HAE)
At close: April 24 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 7 | 6 | 7 | 7 |
Avg. Estimate | 0.89 | 1.03 | 3.96 | 4.4 |
Low Estimate | 0.88 | 0.99 | 3.94 | 4.25 |
High Estimate | 0.92 | 1.09 | 3.99 | 4.6 |
Year Ago EPS | 0.77 | 1.05 | 3.03 | 3.96 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 5 | 6 | 6 |
Avg. Estimate | 329.11M | 328.99M | 1.29B | 1.37B |
Low Estimate | 326.85M | 325.99M | 1.29B | 1.32B |
High Estimate | 332.05M | 334.65M | 1.3B | 1.41B |
Year Ago Sales | 304.42M | -- | 1.17B | 1.29B |
Sales Growth (year/est) | 8.10% | -- | 10.80% | 5.80% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.7 | 0.73 | 0.89 | 0.94 |
EPS Actual | 0.77 | 1.05 | 0.99 | 1.04 |
Difference | 0.07 | 0.32 | 0.1 | 0.1 |
Surprise % | 10.00% | 43.80% | 11.20% | 10.60% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.89 | 1.03 | 3.96 | 4.4 |
7 Days Ago | 0.89 | 1.03 | 3.96 | 4.4 |
30 Days Ago | 0.89 | 1.03 | 3.96 | 4.41 |
60 Days Ago | 0.89 | 1.03 | 3.96 | 4.41 |
90 Days Ago | 0.92 | 1.01 | 3.89 | 4.33 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | 1 | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | 1 | -- | 1 |
Growth Estimates
CURRENCY IN USD | HAE | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 15.60% | -- | -- | 1.50% |
Next Qtr. | -1.90% | -- | -- | 11.40% |
Current Year | 30.70% | -- | -- | 5.20% |
Next Year | 11.10% | -- | -- | 13.40% |
Next 5 Years (per annum) | 12.00% | -- | -- | 11.09% |
Past 5 Years (per annum) | 7.00% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Barrington Research: Outperform to Outperform | 4/12/2024 |
Reiterates | Barrington Research: Outperform to Outperform | 2/13/2024 |
Maintains | Barrington Research: Outperform to Outperform | 11/3/2023 |
Maintains | Citigroup: Neutral to Neutral | 10/2/2023 |
Maintains | Barrington Research: Outperform to Outperform | 8/9/2023 |
Maintains | Barrington Research: Outperform to Outperform | 5/12/2023 |
Related Tickers
MMSI Merit Medical Systems, Inc.
74.03
-0.20%
ICUI ICU Medical, Inc.
96.72
-1.06%
TFX Teleflex Incorporated
211.17
+0.03%
UTMD Utah Medical Products, Inc.
67.16
-0.59%
ANGO AngioDynamics, Inc.
5.87
-2.65%
ATRC AtriCure, Inc.
23.05
-0.52%
ATRI Atrion Corporation
424.19
+4.66%
EMBC Embecta Corp.
10.89
+0.09%
LMAT LeMaitre Vascular, Inc.
64.03
-0.31%
STVN Stevanato Group S.p.A.
27.31
+0.33%